Immunotherapy and Systemic Treatment of Cutaneous Squamous Cell Carcinoma
Cutaneous squamous cell carcinomas (cSCC) represent one of the most diagnosed non-melanoma skin cancers and its incidence is increasing globally. Whereas early stage and low risk cSCC is typically treated with surgery, and in some cases other localized therapeutic modalities, locally advanced or me...
Guardado en:
Autores principales: | Nader Aboul-Fettouh, Daniel Morse, Jigar Patel, Michael R. Migden |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Mattioli1885
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5f50329870c5454eb63b6b30727bf577 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Concurrent development of high-stage cutaneous squamous cell carcinoma during complete response of metastatic cutaneous squamous cell carcinoma to programmed cell death protein 1 blockade with cemiplimab
por: Jacob D. Siegel, MD, et al.
Publicado: (2021) -
Biology and Treatment Advances in Cutaneous Squamous Cell Carcinoma
por: Alesha A. Thai, et al.
Publicado: (2021) -
Cutaneous horns: clues to invasive squamous cell carcinoma being present in the horn base
por: John Pyne, et al.
Publicado: (2013) -
Risk Factors and Diagnosis of Advanced Cutaneous Squamous Cell Carcinoma
por: Gabriella Brancaccio, et al.
Publicado: (2021) -
Laser Immunotherapy: A Potential Treatment Modality for Keratinocyte Carcinoma
por: Silje Haukali Omland, et al.
Publicado: (2021)